vTv Therapeutics (VTVT) Free Cash Flow (2014 - 2026)

vTv Therapeutics has disclosed Free Cash Flow across 13 years of filings, most recently posting -$11.4 million for Q2 2026.

• In Q2 2026, Free Cash Flow fell 126.1% year-over-year to -$11.4 million; the TTM figure through Jun 2026 stood at -$16.7 million (up 23.72% YoY), while the FY2025 annual figure was -$25.1 million, changed 0.23% from the prior year.
• Free Cash Flow came in at -$11.4 million for Q2 2026 at vTv Therapeutics, down from $9.2 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $9.2 million in Q1 2026 to a low of -$11.4 million in Q2 2026.
• Average Free Cash Flow over 5 years is -$4.9 million, with a median of -$5.4 million recorded in 2025.
• Year-over-year, Free Cash Flow tumbled 973.51% in 2023 and soared 261.9% in 2026.
• Over 5 years, Free Cash Flow stood at -$6.9 million in 2022, then soared by 59.17% to -$2.8 million in 2023, then slumped by 70.67% to -$4.8 million in 2024, then sank by 92.47% to -$9.2 million in 2025, then slipped by 24.02% to -$11.4 million in 2026.
• Per Business Quant data, the three most recent Free Cash Flow figures were -$11.4 million in Q2 2026, $9.2 million in Q1 2026, and -$9.2 million in Q4 2025.